NGG vs. GSK
Compare and contrast key facts about National Grid plc (NGG) and GlaxoSmithKline plc (GSK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NGG or GSK.
Correlation
The correlation between NGG and GSK is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NGG vs. GSK - Performance Comparison
Key characteristics
NGG:
0.06
GSK:
-0.57
NGG:
0.23
GSK:
-0.68
NGG:
1.04
GSK:
0.92
NGG:
0.07
GSK:
-0.44
NGG:
0.19
GSK:
-0.93
NGG:
8.32%
GSK:
13.53%
NGG:
24.05%
GSK:
22.07%
NGG:
-54.85%
GSK:
-55.21%
NGG:
-14.15%
GSK:
-25.45%
Fundamentals
NGG:
$58.25B
GSK:
$68.21B
NGG:
$2.52
GSK:
$1.48
NGG:
23.62
GSK:
22.59
NGG:
1.84
GSK:
0.77
NGG:
$11.36B
GSK:
$23.26B
NGG:
$3.56B
GSK:
$16.84B
NGG:
$4.26B
GSK:
$6.82B
Returns By Period
In the year-to-date period, NGG achieves a 0.19% return, which is significantly higher than GSK's -1.15% return. Over the past 10 years, NGG has outperformed GSK with an annualized return of 4.87%, while GSK has yielded a comparatively lower 1.86% annualized return.
NGG
0.19%
1.76%
-2.55%
1.73%
4.85%
4.87%
GSK
-1.15%
-0.51%
-13.35%
-12.42%
-2.97%
1.86%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NGG vs. GSK — Risk-Adjusted Performance Rank
NGG
GSK
NGG vs. GSK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for National Grid plc (NGG) and GlaxoSmithKline plc (GSK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NGG vs. GSK - Dividend Comparison
NGG's dividend yield for the trailing twelve months is around 11.79%, more than GSK's 4.66% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NGG National Grid plc | 11.79% | 11.81% | 5.20% | 5.13% | 4.71% | 5.29% | 4.90% | 6.44% | 24.15% | 5.07% | 4.73% | 7.86% |
GSK GlaxoSmithKline plc | 4.66% | 4.60% | 3.75% | 4.78% | 4.92% | 5.49% | 4.28% | 5.55% | 5.72% | 7.06% | 5.96% | 6.09% |
Drawdowns
NGG vs. GSK - Drawdown Comparison
The maximum NGG drawdown since its inception was -54.85%, roughly equal to the maximum GSK drawdown of -55.21%. Use the drawdown chart below to compare losses from any high point for NGG and GSK. For additional features, visit the drawdowns tool.
Volatility
NGG vs. GSK - Volatility Comparison
National Grid plc (NGG) has a higher volatility of 6.32% compared to GlaxoSmithKline plc (GSK) at 5.97%. This indicates that NGG's price experiences larger fluctuations and is considered to be riskier than GSK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NGG vs. GSK - Financials Comparison
This section allows you to compare key financial metrics between National Grid plc and GlaxoSmithKline plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities